Clinical Trials
15
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials
To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension
- Conditions
- Essential Hypertension
- First Posted Date
- 2025-07-04
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Lepu Medical Technology (Beijing) Co., Ltd.
- Target Recruit Count
- 213
- Registration Number
- NCT07051811
- Locations
- 🇨🇳
Beijing Anzhen hospital , Capital Medical University, Beijing, Beijing, China
🇨🇳China-Japan Friendship Hospital, Beijing, Beijing, China
🇨🇳Peking University First Hospital, Beijing, Beijing, China
To Evaluate the Efficacy and Safety of Multi-parameter Non-Invasive Glucose Sensors for for Blood Glucose Measurement
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2023-08-30
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Lepu Medical Technology (Beijing) Co., Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT06017349
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Study on the Efficacy and Safety of Rechargeable Implantable DBS System in the Treatment of Parkinson's Disease
- Conditions
- Parkinson Disease
- First Posted Date
- 2023-08-18
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- Lepu Medical Technology (Beijing) Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05997667
- Locations
- 🇨🇳
Xuanwu Hospital Capital Medical University, Beijing, Beijing, China
🇨🇳The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
🇨🇳ZhuJiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Treatment of Urethral Stricture With Urethral Drug Ball
- Conditions
- Urethral Stricture Less Than 2 cm
- First Posted Date
- 2023-04-13
- Last Posted Date
- 2023-04-13
- Lead Sponsor
- Lepu Medical Technology (Beijing) Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT05812482
- Locations
- 🇨🇳
Beijing Hospital, Beijing, Beijing, China
Ultrasound Ablation for Essential Hypertension（FIM）
- Conditions
- Uncontrolled Essential Hypertension
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- Lepu Medical Technology (Beijing) Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT05795829
- Locations
- 🇨🇳
The Second Affiuated Hospital of Chongqing Medical University, Chongqing, China
🇨🇳The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Prev
- 1
- 2
- 3
- Next